摘要
青少年及年轻成年人(AYA)非霍奇金淋巴瘤(NHL)与儿童和高龄成年患者的特征、病理类型、遗传学特点等方面存在差异,且目前缺乏标准治疗方案。文章简述了AYA-NHL的流行病学、分子生物学特点、预后因素等,着重介绍了不同病理类型患者接受不同治疗方案后获得的相应疗效,旨在为临床标准方案的制定提供依据。
Adolescent and young adult(AYA)non-Hodgkin lymphoma(NHL)is different from children and older adults in patients'clinical characteristics,pathological subtypes and genetic characteristics.The standard treatment regimen is still unclear currently.This article briefly describes the epidemiology,molecular biological features and prognostic factors of AYA-NHL,and highlights the curative effects of different treatment options in various subtypes of AYA-NHL,aiming to provide a basis for making clinical standard treatment plans.
作者
许艳洁
黄俊廷
张翼鷟
Xu Yanjie;Huang Junting;Zhang Yizhuo(Department of Pediatric Oncology,Sun Yat-Sen University Cancer Center,Key National Oncology Laboratory of South China,Guangzhou 510060,China)
出处
《白血病．淋巴瘤》
CAS
2020年第11期641-644,共4页
Journal of Leukemia & Lymphoma
关键词
青少年
成年人
淋巴瘤
非霍奇金
综合疗法
Adolescent
Adult
Lymphoma,non-Hodgkin
Combined modality therapy
